𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical diagnostic criteria for dementia associated with Parkinson's disease

✍ Scribed by Murat Emre; Dag Aarsland; Richard Brown; David J. Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W. Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
154 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Current treatment of dementia with Lewy
✍ David J. Burn; Ian G. McKeith πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

Dementia in Parkinson's disease (PDD) is a frequent and distressing complication with major consequences. Clinical and pathological features closely link PDD and dementia with Lewy bodies (DLB), suggesting they represent part of the same disease spectrum. Although dopaminergic deficiency primarily d

Cognitive correlates of visual hallucina
✍ Kolbjorn Bronnick; Murat Emre; Sibel Tekin; Siri B. Haugen; Dag Aarsland πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

## Abstract ## Background: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease de

Randomized controlled trial of memantine
✍ Iracema Leroi; Ross Overshott; E. Jane Byrne; Emily Daniel; Alistair Burns πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 338 KB πŸ‘ 1 views

## Abstract The objective of this study is to investigate the safety and tolerability of memantine, a glutamatergic modulator, in patients suffering from dementia associated with Parkinson's disease (PDD), an increasingly common complication of PD. This was a 22‐week trial of 25 participants with a